=Aphria (APHA) reported earnings on Tue 14 Jan 20 (b/o)

Aphria misses by CAD 0.01, misses on revs; lowers FY20 revenue guidance 

Reports Q2 (Nov) loss of CAD 0.03 per share, CAD 0.01 worse than the two analyst estimate of (CAD 0.02); revenues rose 455.8% year/year to CAD 120.6 mln vs the CAD 128.38 mln S&P Capital IQ Consensus.

Co issues lowered guidance for FY20, sees FY20 revs of CAD 575-625 mln from $650-700 mln vs. CAD 584.81 mln S&P Capital IQ Consensus; adjusted EBITDA of CAD 35-42 mln.

Carl Merton, Aphria's Chief Financial Officer commented, "We are updating our annual outlook with a little over four months left in our fiscal year to reflect certain market dynamics that have evolved relative to our initial expectations. We look forward to generating an acceleration in our revenue and profit growth in the second half of the fiscal year and continue to believe the Canadian and international cannabis industry outlook remains robust. Aphria is well positioned for long-term sustainable growth as we continue to manage the controllable aspects of our business."